Results 1,981-2,000 of 12,682 for speaker:Louise O'Reilly

Written Answers — Department of Health: Hospital Services (14 Nov 2017)

Louise O'Reilly: 280. To ask the Minister for Health the reason St Vincent's University Hospital has ceased to offer spinal review appointments in its orthopaedic department; and if he will make a statement on the matter. [47708/17]

Written Answers — Department of Health: Hospital Waiting Lists Data (14 Nov 2017)

Louise O'Reilly: 281. To ask the Minister for Health the number of persons who have been affected due to St Vincent's University Hospital ceasing to offer spinal review appointments in its orthopaedic department; the location to which these persons will be reallocated to; and if he will make a statement on the matter. [47709/17]

Written Answers — Department of Health: Long-Term Illness Scheme Eligibility (14 Nov 2017)

Louise O'Reilly: 342. To ask the Minister for Health his plans to grant pregnant women diagnosed with gestational diabetes temporary long term illness status in order to allow them access free medicines and testing strips to monitor their condition (details supplied); and if he will make a statement on the matter. [48125/17]

Ceisteanna - Questions (Resumed) - Priority Questions: Emergency Departments (15 Nov 2017)

Louise O'Reilly: I am pretty sure the Minister does not want to encourage people to get the flu, especially after last year.

Ceisteanna - Questions (Resumed) - Priority Questions: Medical Products (15 Nov 2017)

Louise O'Reilly: 22. To ask the Minister for Health when his attention was drawn to the side effects and complications of transvaginal mesh implant procedures; the steps he has taken to address and take control of the situation; if he will instruct the HSE to establish a register of women impacted by complications from the procedure; and if he will make a statement on the matter. [48282/17]

Ceisteanna - Questions (Resumed) - Priority Questions: Medical Products (15 Nov 2017)

Louise O'Reilly: This fairly simple question relates to the complications associated with transvaginal mesh implants. The details of some of the serious complications do not make for easy reading for anyone. Those who have met the people affected by this issue will appreciate that it is serious. This question gives the Minister an opportunity to tell me what he is doing about this matter.

Ceisteanna - Questions (Resumed) - Priority Questions: Medical Products (15 Nov 2017)

Louise O'Reilly: To be honest, I do not think the Minister is taking this matter at all seriously. I asked him when his attention was drawn to this issue. He has advised me that he read about it in the media. It strikes me as odd that his officials have not kept him informed about this problem, especially because multi-party actions in this respect are under way in a number of other countries. We...

Ceisteanna - Questions (Resumed) - Priority Questions: Medical Products (15 Nov 2017)

Louise O'Reilly: I did not use that language.

Ceisteanna - Questions (Resumed) - Priority Questions: Medical Products (15 Nov 2017)

Louise O'Reilly: Regarding the phrase "give a damn", I do not use language like that in here but I stand over what I said. The issue of women's health has been discussed here time out of number and the Minister is aware of that, as am I. It was not intended to be in any way personal. Of course, I welcome the fact that the chief medical officer will examine this but I would like to hear the Minister say...

Other Questions: Health Services Expenditure (15 Nov 2017)

Louise O'Reilly: The Minister is on a roll.

Other Questions: Medicinal Products Regulation (15 Nov 2017)

Louise O'Reilly: 30. To ask the Minister for Health his plans to undertake an investigation into the current and historical use of the drug, sodium valproate; if a State-wide register of those women who were on the medicine during pregnancy, and of the children affected by foetal anti-convulsant syndrome caused by exposure to sodium valproate during pregnancy, will be established; if appropriate pathways for...

Other Questions: Medicinal Products Regulation (15 Nov 2017)

Louise O'Reilly: I hope the two issues I am raising today will not be matters we will be discussing for a long time but will be addressed. The first issue relates to sodium valproate, more commonly known as Epilim, taken by women with epilepsy during pregnancy. The HSE is aware it has been shown to have serious health implications for pregnant women in particular.

Other Questions: Medicinal Products Regulation (15 Nov 2017)

Louise O'Reilly: Those developments are welcome. Information is available that sodium valproate should not be prescribed to girls or women of child-bearing age or pregnant women unless alternative treatments are ineffective or not tolerated. Yesterday evening, I received an email from a woman of child-bearing age, which I am happy to share with the Minister outside of the Chamber, in which she described...

Other Questions: Medicinal Products Regulation (15 Nov 2017)

Louise O'Reilly: It is welcome that such an instruction would go out. We are not saying the medicine is necessarily dangerous but it is in certain circumstances. The more awareness there is, the better. The actions being taken now are somewhat for the future. I have met some of the women affected and their children, some of whom are adults. They have been profoundly affected by this drug. I am not a...

Health and Social Care Professionals (Amendment) Bill 2017: Report and Final Stages (15 Nov 2017)

Louise O'Reilly: I move amendment No. 1:In page 3, between lines 14 and 15, to insert the following:“Amendment of section 4 of Principal Act 2. Section 4(1) of the Principal Act is amended by the insertion of the following after paragraph (l):“(m) counsellors, that is to say, a person or organisation who engages in, and holds himself, herself or itself out as having experience or expertise to...

Health and Social Care Professionals (Amendment) Bill 2017: Report and Final Stages (15 Nov 2017)

Louise O'Reilly: That is outrageous.

Health and Social Care Professionals (Amendment) Bill 2017: Report and Final Stages (15 Nov 2017)

Louise O'Reilly: Hear, hear.

Health and Social Care Professionals (Amendment) Bill 2017: Report and Final Stages (15 Nov 2017)

Louise O'Reilly: Hear, hear.

Health and Social Care Professionals (Amendment) Bill 2017: Report and Final Stages (15 Nov 2017)

Louise O'Reilly: Yes.

Written Answers — Department of Health: Industrial Disputes (15 Nov 2017)

Louise O'Reilly: 36. To ask the Minister for Health the position regarding the possibility of a strike by workers in section 39 agencies; the steps that he has taken to address the underlying issues which may lead to a strike; his plans to unwind the FEMPI cuts imposed on section 39 agencies; and if he will make a statement on the matter. [48113/17]